STOCKSCREENR

AMGN

NASDAQ

Amgen Inc.

$346.25+8.23(+2.43%)Mkt Cap: $186.65B

Key Stats

Market Cap

$186.65B

P/E Ratio

24.33

EPS

$14.23

Dividend Yield

2.84%

52-Week Range

$261.43 — $391.29

Volume

3.55M

Avg Volume

2.71M

Beta

0.47

Price Alerts for AMGN

Get alerted when AMGN hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

24.33

Forward P/E

15.46

PEG Ratio

0.27

P/S (TTM)

4.98

P/B (TTM)

21.14

P/FCF

183.58

EV/EBITDA

63.76x

EV/Sales

—

Financial Health

ROE (TTM)

0.97%

ROA (TTM)

0.09%

ROIC

0.06%

Gross Margin

0.70%

Operating Margin

0.28%

Net Margin

0.14%

Debt/Equity

6.31

Current Ratio

1.14

Growth

EPS Growth (YoY)

+1.13%

Revenue Growth (YoY)

+0.09%

EPS Growth (3Y)

+0.17%

EPS Growth (5Y)

+0.11%

Sales Growth (3Y)

+0.12%

Sales Growth (5Y)

+0.08%

EPS Est (This Year)

$22.40

EPS Est (Next Year)

$23.33

Dividends

Dividend Yield

—

Annual Dividend

$2.38

Payout Ratio

0.96%

Frequency

—

Ex-Dividend Date

2025-11-21

Cash/Share

$16.94

Analyst Consensus

2.8

Hold

1 = Strong Buy, 5 = Strong Sell

Price Target Range

$185.00$357.50$432.00
LowMedianHigh

Consensus Target: $347.57(0.4% upside)

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

-25291

Outstanding Shares

539.07M

Float

537.73M

Free Float %

99.75%

Technicals

RSI (14)

55.30

SMA 20

$375.80

SMA 50

$353.60

SMA 200

$314.41

ATR (14)

9.43

Volatility (Week)

0.02%

Volatility (Month)

0.02%

Pattern

—

Performance

1 Day

+2.01%

1 Week

-2.26%

1 Month

+2.49%

3 Months

+10.82%

6 Months

+32.90%

1 Year

—

YTD

+15.06%

All-Time High

$385.12

About

Sector

Healthcare

Industry

Drug Manufacturers - General

Country

US

Exchange

NASDAQ

IPO Date

1983-06-17

Employees

28000

CEO

Robert A. Bradway

Index Membership

Dow Jones, S&P 500

Website

https://www.amgen.com

Amgen Inc. (AMGN) is a healthcare company in the drug manufacturers - general industry listed on the NASDAQ. With a market capitalization of $186.65B, a P/E ratio of 24.33, and a dividend yield of 2.84%, AMGN is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare AMGN against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NVO

Novo Nordisk A/S

$42.22

+4.79%

$187.63B

AZN

AstraZeneca PLC

$187.37

+1.17%

$290.48B

MRK

Merck & Co., Inc.

$109.15

-1.62%

$269.59B

JNJ

Johnson & Johnson

$229.85

+1.10%

$553.30B

PFE

Pfizer Inc.

$26.70

+1.68%

$151.88B

ABBV

AbbVie Inc.

$211.33

+3.65%

$373.79B

Frequently Asked Questions

What is Amgen Inc.'s P/E ratio?

Amgen Inc. (AMGN) has a trailing twelve-month (TTM) P/E ratio of 24.33. This is near the market average range. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Amgen Inc. pay a dividend?

No, Amgen Inc. (AMGN) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Amgen Inc.'s market cap?

Amgen Inc. (AMGN) has a market capitalization of $186.65 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

What do analysts think about AMGN?

Wall Street analysts have a consensus "Hold" rating on Amgen Inc. (AMGN) with an average score of 2.80 on a 1-5 scale (1 = Strong Buy, 5 = Strong Sell). The consensus price target of $347.57 implies 0.4% upside from the current price.

How has AMGN performed this year?

Amgen Inc. (AMGN) has returned +15.06% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.